S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

HEPA Hepion Pharmaceuticals Inc

0.29

0.0025 (0.87%)

29 Apr 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Hepion Pharmaceuticals (NASDAQ:HEPA)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Hepion Pharmaceuticals Charts.

Hepion Pharmaceuticals (NASDAQ:HEPA)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Hepion Pharmaceuticals Charts.

Hepion Pharmaceuticals Inc News

Form PRER14A - Preliminary Proxy Soliciting materials
Thursday 24 April 2025 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 21 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 20 March 2025 (1 month ago) • Edgar (US Regulatory)

Hepion Pharmaceuticals Announces Reverse Stock Split
Friday 14 March 2025 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 11 March 2025 (2 months ago) • Edgar (US Regulatory)

Hepion Pharmaceuticals Announces $9.0 Million Public Offering
Thursday 23 January 2025 (3 months ago) • GlobeNewswire Inc.

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Monday 13 January 2025 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 12 December 2024 (5 months ago) • Edgar (US Regulatory)

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
Thursday 12 December 2024 (5 months ago) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Friday 6 December 2024 (5 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 3 December 2024 (5 months ago) • Edgar (US Regulatory)

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Tuesday 3 December 2024 (5 months ago) • GlobeNewswire Inc.

More Hepion Pharmaceuticals Inc News Articles

Vanguard Eur Corporate B...

Global X S&p 500 Annual ...

Xtrackers Esg Usd Emergi...

Thermo Fisher Scientific

Wisdomtree Eur Governmen...

GraniteShares 5x Long MI...

Graniteshares 3x Short A...

Invesco Goldman Sachs Eq...

db Physical Silver ETC

Augustum Market Timing C...

Invesco S&P MidCap 400 P...

Invesco Physical Gold ETC

Global X Autonomous & El...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions